Inspire Medical Systems Management

Management criteria checks 2/4

Inspire Medical Systems' CEO is Tim Herbert, appointed in Nov 2007, has a tenure of 16.5 years. total yearly compensation is $7.49M, comprised of 9.2% salary and 90.8% bonuses, including company stock and options. directly owns 0.98% of the company’s shares, worth €69.60M. The average tenure of the management team and the board of directors is 4.3 years and 7.3 years respectively.

Key information

Tim Herbert

Chief executive officer

US$7.5m

Total compensation

CEO salary percentage	9.2%
CEO tenure	16.5yrs
CEO ownership	1.0%
Management average tenure	4.3yrs
Board average tenure	7.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Tim Herbert's remuneration changed compared to Inspire Medical Systems's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	US$7m	US$690k	-US$21m
Sep 30 2023	n/a	n/a	-US$33m
Jun 30 2023	n/a	n/a	-US$41m
Mar 31 2023	n/a	n/a	-US$44m
Dec 31 2022	US$6m	US$645k	-US$45m
Sep 30 2022	n/a	n/a	-US$50m
Jun 30 2022	n/a	n/a	-US$44m
Mar 31 2022	n/a	n/a	-US$43m
Dec 31 2021	US$1m	US$620k	-US$42m
Sep 30 2021	n/a	n/a	-US$47m
Jun 30 2021	n/a	n/a	-US$47m
Mar 31 2021	n/a	n/a	-US$57m
Dec 31 2020	US$5m	US$506k	-US$57m
Sep 30 2020	n/a	n/a	-US$59m
Jun 30 2020	n/a	n/a	-US$57m
Mar 31 2020	n/a	n/a	-US$41m
Dec 31 2019	US$3m	US$440k	-US$33m
Sep 30 2019	n/a	n/a	-US$29m
Jun 30 2019	n/a	n/a	-US$25m
Mar 31 2019	n/a	n/a	-US$24m
Dec 31 2018	US$3m	US$418k	-US$22m
Sep 30 2018	n/a	n/a	-US$21m
Jun 30 2018	n/a	n/a	-US$21m
Mar 31 2018	n/a	n/a	-US$20m
Dec 31 2017	US$600k	US$380k	-US$18m

Compensation vs Market: Tim's total compensation ($USD7.49M) is above average for companies of similar size in the German market ($USD3.35M).

Compensation vs Earnings: Tim's compensation has increased whilst the company is unprofitable.

CEO

Tim Herbert (60 yo)

16.5yrs

Tenure

US$7,490,775

Compensation

Mr. Timothy P. Herbert, also known as Tim, has been Chief Executive Officer, President and Director of Inspire Medical Systems, Inc. since November 2007. He is the Founder of Inspire Medical Systems, Inc....

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Timothy Herbert	CEO, President & Director	16.5yrs	US$7.49m	0.98% $ 69.6m
Richard Buchholz	Chief Financial Officer	10yrs	US$2.30m	0.10% $ 7.1m
Philip Ebeling	Chief Operating Officer	3.9yrs	US$2.31m	0.0011% $ 77.8k
Randall Ban	Chief Commercial Officer	5.3yrs	US$2.26m	0.0022% $ 155.5k
Charisse Sparks	Chief Medical Officer	less than a year	US$211.35k	0.0011% $ 77.1k
Carlton Weatherby	Chief Strategy Officer	less than a year	US$2.10m	0% $ 0
John Rondoni	Chief Technology Officer	2yrs	US$2.10m	0.028% $ 2.0m
Ezgi Yagci	Vice President of Investor Relations	no data	no data	no data
Bryan Phillips	Senior VP	3.3yrs	US$2.69m	0.0043% $ 305.4k
Steven Jandrich	Vice President of Human Resources	6.7yrs	US$1.99m	0.079% $ 5.6m
Ivan Lubogo	Senior Vice President of U.S. Sales	4.3yrs	no data	no data
Andreas Henke	Executive VP & MD of Europe	4.3yrs	no data	no data

4.3yrs

Average Tenure

55yo

Average Age

Experienced Management: 2DR's management team is considered experienced (4.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Timothy Herbert	CEO, President & Director	16.5yrs	US$7.49m	0.98% $ 69.6m
Casey Tansey	Independent Director	16.3yrs	US$235.88k	0.068% $ 4.8m
Dana Mead	Independent Director	15.8yrs	US$238.38k	0.066% $ 4.7m
Shawn McCormick	Independent Director	7.3yrs	US$248.38k	0.048% $ 3.4m
Jerry Griffin	Independent Director	16.3yrs	US$235.88k	0.034% $ 2.4m
Marilyn Nelson	Independent Chair of the Board & Lead Director	7.5yrs	US$275.14k	0.11% $ 7.9m
Shelley Broader	Independent Director	3.6yrs	US$243.38k	0.0030% $ 214.9k
Gary Ellis	Independent Director	4.8yrs	US$243.38k	0.0087% $ 615.0k
Georgia Garinois-Melenikiotou	Independent Director	3.8yrs	US$238.38k	0.0024% $ 167.5k
Cynthia Burks	Independent Director	1.8yrs	US$235.88k	0% $ 0
Myriam Curet	Independent Director	less than a year	US$271.56k	no data

7.3yrs

Average Tenure

64yo

Average Age

Experienced Board: 2DR's board of directors are considered experienced (7.3 years average tenure).

Inspire Medical Systems Management

Management criteria checks 2/4

Key information

Recent management updates

Inspire Medical Systems, Inc. Announces Board Retirements

Inspire Medical Systems, Inc., Annual General Meeting, May 02, 2024

Inspire Medical Systems, Inc. Announces Jerry C. Griffin, M.D. from Its Board of Directors, Effective on May 2, 2024

Inspire Medical Systems, Inc. Announces Appointment of Myriam J. Curet as Independent Director

Insufficient new directors

Inspire Medical Systems, Inc. Announces the Addition of Charisse Y. Sparks, M.D., as Chief Medical Officer

Recent updates

Now 21% undervalued

Inspire Medical Systems, Inc. to Report Q1, 2024 Results on May 07, 2024

New minor risk - Shareholder dilution

Full year 2023 earnings released: US$0.72 loss per share (vs US$1.60 loss in FY 2022)

Inspire Medical Systems, Inc. Reaffirms Revenue Guidance for the Full Year 2024

Inspire Medical Systems, Inc. Announces Board Retirements

Inspire Medical Systems, Inc., Annual General Meeting, May 02, 2024

Inspire Medical Systems, Inc. Announces Jerry C. Griffin, M.D. from Its Board of Directors, Effective on May 2, 2024

Inspire Medical Systems, Inc. to Report Q4, 2023 Results on Feb 06, 2024

Forecast to breakeven in 2025

Inspire Medical Systems, Inc. to Report Fiscal Year 2023 Results on Jan 08, 2024

Inspire Medical Systems, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023 and Full Year 2024

Inspire Medical Systems, Inc. Announces Appointment of Myriam J. Curet as Independent Director

Gainey McKenna & Egleston Announces A Class Action Lawsuit Filed Against Inspire Medical Systems Inc

New minor risk - Shareholder dilution

Inspire Medical Systems, Inc. Revises Revenue Guidance for the Full Year 2023

Third quarter 2023 earnings released: US$0.29 loss per share (vs US$0.60 loss in 3Q 2022)

Now 22% undervalued after recent price drop

Insufficient new directors

New minor risk - Share price stability

Now 29% undervalued after recent price drop

Inspire Medical Systems, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Second quarter 2023 earnings released: US$0.41 loss per share (vs US$0.53 loss in 2Q 2022)

Inspire Medical Systems, Inc. Announces the Addition of Charisse Y. Sparks, M.D., as Chief Medical Officer

Inspire Medical Systems, Inc. Appoints Carlton Weatherby as Chief Strategy Officer

Inspire Medical Systems, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Inspire Medical Systems, Inc.(NYSE:INSP) dropped from Russell 2000 Dynamic Index

First quarter 2023 earnings released: US$0.53 loss per share (vs US$0.61 loss in 1Q 2022)

Full year 2022 earnings released: US$1.60 loss per share (vs US$1.54 loss in FY 2021)

Forecast to breakeven in 2025

Inspire Medical Systems, Inc. Provides Revenue Guidance for the Full Year 2023

Inspire Medical Systems, Inc. to Report Q4, 2022 Results on Feb 07, 2023

Inspire Medical Systems, Inc. to Report Fiscal Year 2022 Results on Feb 07, 2023

Third quarter 2022 earnings released: US$0.60 loss per share (vs US$0.38 loss in 3Q 2021)

Inspire Medical Systems, Inc. Updates Revenue Guidance for the Full Year of 2022

Inspire Medical Systems, Inc. to Report Q3, 2022 Results on Nov 01, 2022

Inspire Medical Systems, Inc. has completed a Follow-on Equity Offering in the amount of $215 million.

Second quarter 2022 earnings released: US$0.53 loss per share (vs US$0.48 loss in 2Q 2021)

Inspire Medical Systems, Inc. Revises Earnings Guidance for Full Year 2022

Inspire Medical Systems, Inc. Announces Appointment of Two New Independent Directors to Its Board

Inspire Medical Systems, Inc. Announces United States Food and Drug Administration Approval of Expanded, Full-Body MRI Compatibility with Inspire Therapy

Inspire Medical Systems, Inc. to Report Q2, 2022 Results on Aug 02, 2022

First quarter 2022 earnings released: US$0.61 loss per share (vs US$0.60 loss in 1Q 2021)

Inspire Medical Systems, Inc. Revises Revenue Guidance for the Year 2022

Inspire Medical Systems, Inc. to Report Q1, 2022 Results on May 03, 2022

Inspire Medical Systems, Inc. Provides Revenue Guidance for the Full Year 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Third quarter 2021 earnings released: US$0.38 loss per share (vs US$0.39 loss in 3Q 2020)

Inspire Medical Systems, Inc. Provides Revenue Guidance for the Full Year 2021

Second quarter 2021 earnings released: US$0.48 loss per share (vs US$0.88 loss in 2Q 2020)

Inspire Medical Systems, Inc. Announces Positive Coverage Policy Issued by Anthem for Inspire Therapy

First quarter 2021 earnings released: US$0.60 loss per share (vs US$0.67 loss in 1Q 2020)

Inspire Medical Systems, Inc. Provides Revenue Guidance for the Full Year 2021

Inspire Medical Systems, Inc., Annual General Meeting, Apr 29, 2021

Inspire Medical Systems, Inc. Announces FDA Approval of Two-Incision Implant Procedure

Revenue beats expectations

Full year 2020 earnings released: US$2.19 loss per share (vs US$1.40 loss in FY 2019)

New 90-day high: €189

Inspire Medical Systems, Inc. to Report Q4, 2020 Results on Feb 23, 2021

New 90-day high: €176

New 90-day high: €154

Inspire Medical Systems, Inc. Announces Full Integration of Inspire Therapy into German DRG Reimbursement System to Begin in 2021

New 90-day high: €140

Third quarter 2020 earnings released: US$0.39 loss per share

Revenue beats expectations

Inspire Medical Systems, Inc. to Report Q3, 2020 Results on Nov 02, 2020

New 90-day high: €111

New 90-day high - €105

Independent Director recently sold €2.8m worth of stock